Listed

SAB Biotherapeutics, Inc.: Form 8-K, filed Jan 3, 2024

Filed with the SEC on Jan 3, 2024 and accepted by EDGAR at Jan 3, 2024, 09:00 ET.

Share

Share this page

Story card, 1080 × 1920

Items reported

  • Item 3.03 Change to security holders’ rights
  • Item 5.03 Amendment to articles or bylaws
  • Item 5.07 Shareholder vote results
  • Item 7.01 Regulation FD disclosure
  • Item 9.01 Financial statements and exhibits

Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.

Source: SEC EDGAR, the filing index for accession 0000950170-24-000543. Last ingested by Listed: Nov 5, 2026, 12:06 ET. Listed shows no prices and gives no investment advice.